Joan M Fallon

US Patent:

6632429, Oct 14, 2003

Filed:

Nov 7, 2000

Appl. No.:

09/707395

Inventors:

Joan M. Fallon - New Rochelle NY 10801

International Classification:

A61K 3843

US Classification:

424 941, 424 942, 514 2

Abstract:

A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and in particular, as a prognosticative of potential secretin, other neuropeptides, peptides, and digestive enzyme administration for persons having ADD, ADHD, Autism and other PDD related disorders.

US Patent:

6660831, Dec 9, 2003

Filed:

Aug 14, 2001

Appl. No.:

09/929592

Inventors:

Joan M. Fallon - Yonkers NY 10704

International Classification:

A61K 3800

US Classification:

530309, 4241981, 514 12

Abstract:

Methods for aiding in the diagnosis of dysautonomic disorders and dysautonomic conditions and methods for treating individuals diagnosed as having a dysautonomic disorder or a dysautonomic condition. In one aspect, a diagnosis method comprising analyzing a stool sample of an individual for the presence of a biological marker wherein the quantity of the biological marker is an indication of whether the invidual has, or can develop, a dysuatonic disorder or dysautonomic condition, as well as a therapuetic method for treating a dysautonomic disorder or dysautonomic condition by administration of, e. g. , secretin, neuropeptides, peptides and/or digestive enzymes.

US Patent:

7138123, Nov 21, 2006

Filed:

Dec 8, 2003

Appl. No.:

10/730567

Inventors:

Joan M. Fallon - Yonkers NY, US

International Classification:

A61K 39/00

US Classification:

4241981, 514 2, 530309

Abstract:

Methods for aiding in the diagnosis of dysautonomic disorders and dysautonomic conditions and methods for treating individuals diagnosed as having a dysautonomic disorder or a dysautonomic condition. In one aspect, a diagnosis method comprising analyzing a stool sample of an individual for the presence of a biological marker wherein the quantity of the biological marker is an indication of whether the individual has, or can develop, a dysautonomic disorder or dysautonomic condition, as well as a therapeutic method for treating a dysautonomic disorder or dysautonomic condition by administration of, e. g. , secretin, neuropeptides, peptides and/or digestive enzymes.

US Patent:

8008036, Aug 30, 2011

Filed:

Sep 25, 2008

Appl. No.:

12/238415

Inventors:

Joan M. Fallon - Yonkers NY, US

Assignee:

Curemark, LLC - Rye NY

International Classification:

C12Q 1/37
G01N 30/00

US Classification:

435 23, 435 24, 435 4, 435803, 436173

Abstract:

A method for confirming a diagnosis of autism in an individual comprises obtaining a sample of feces from an individual, determining a quantitative level of chymotrypsin present in the sample, and comparing the quantitative level of fecal chymotrypsin in the stool sample of the person having autism to a stool sample from an individual that has a normal fecal chymotrypsin level and does not have autism and confirming a diagnosis of autism based on the measurement of the quantitative level of fecal chymoptrypsin.

US Patent:

8012710, Sep 6, 2011

Filed:

Jun 19, 2009

Appl. No.:

12/487868

Inventors:

Joan M. Fallon - Bronxville NY, US

Assignee:

Curemark, LLC - Rye NY

International Classification:

C12Q 1/37
C07K 7/00

US Classification:

435 23, 530309

Abstract:

A method for treating a Parkinson's patient with digestive/pancreatic enzymes involves administering an effective amount of digestive/pancreatic enzymes to an individual having the disorder in order to improve a symptom of the disorder. In addition, a method is provided for determining whether an individual has, or may develop, Parkinson's disease or related dysautonomic disorders and for determining whether an individual will benefit from the administration of pancreatic/digestive enzymes to treat the dysautonomic disorder.

US Patent:

8012930, Sep 6, 2011

Filed:

Mar 11, 2008

Appl. No.:

12/046402

Inventors:

Joan M. Fallon - Yonkers NY, US

Assignee:

Curemark, LLC - Rye NY

International Classification:

A61K 35/39
A61K 35/37
A61K 38/54
C12Q 1/00

US Classification:

514 55, 514 128, 514 175, 424 9421, 424 942, 435 4

Abstract:

A therapeutic method for treating an individual diagnosed with PDD pervasive developmental disorder comprises determining the efficacy of digestive enzyme administration for the treatment of the individual based on a measure of the individual's chymotrypsin level, and administering digestive enzymes to the individual based on the determination of the measure of the individual's chymotrypsin level. A method for reducing the amount of methylphenidate (Ritalin) being taken by an individual with attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) by administering a therapeutic amount of digestive enzymes is also provided.

US Patent:

8030002, Oct 4, 2011

Filed:

Nov 16, 2001

Appl. No.:

09/990909

Inventors:

Joan M. Fallon - Yonkers NY, US

Assignee:

Curemark LLC - Rye NY

International Classification:

G01N 33/53
G01N 33/554
G01N 33/573
C12Q 1/02

US Classification:

435 71, 435 72, 435 732, 435 74, 435 29

Abstract:

Methods for aiding in the diagnosis of disorders including, but not limited to, PDDs (Pervasive Development Disorders), Dysautonomic disorders, Parkinson's disease and SIDS (Sudden Infant Death Syndrome). In one aspect, a diagnosis method comprises analyzing a stool sample of an individual for the presence of a biological marker (or marker compound) comprising one or more pathogens, which provides an indication of whether the individual has, or can develop, a disorder including, but not limited to, a PDD, Dysautonomia, Parkinsons disease and SIDS. Preferably, the presence of one or more pathogens is determined using a stool immunoassay to determine the presence of antigens in a stool sample, wherein such antigens are associated with one or more pathogens including, but not limited to, , Adenovirus, Rotavirus or.

US Patent:

8084025, Dec 27, 2011

Filed:

Apr 20, 2009

Appl. No.:

12/426794

Inventors:

Joan M. Fallon - Bronxville NY, US

Assignee:

Curemark LLC - Rye NY

International Classification:

A61K 38/46

US Classification:

424 946, 424 9463, 424 9461, 435195, 435198, 435201, 435202, 435212, 435213, 435219

Abstract:

A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the gastrointestinal tract to determine the presence of symptoms of addiction, and the likelihood of relapsing into addiction is disclosed.